TASK DEFINITION: In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
PROBLEM: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Research on Human Fetal Tissue 
Amendments of 1993''.

SEC. 2. ESTABLISHMENT OF AUTHORITIES AND PROTECTIONS REGARDING 
              TRANSPLANTATION OF HUMAN FETAL TISSUE.

    Part G of title IV of the Public Health Service Act (42 U.S.C. 289 
et seq.) is amended by inserting after section 498 the following new 
section:

             ``research on transplantation of fetal tissue

    ``Sec. 498A. (a) Establishment of Program.--
            ``(1) In general.--The Secretary may conduct or support 
        research on the transplantation of human fetal tissue for 
        therapeutic purposes.
            ``(2) Source of tissue.--Human fetal tissue may be used in 
        research carried out under paragraph (1) regardless of whether 
        the tissue is obtained pursuant to a spontaneous or induced 
        abortion or pursuant to a stillbirth.
    ``(b) Informed Consent of Donor.--
            ``(1) In general.--In research carried out under subsection 
        (a), human fetal tissue may be used only if the woman providing 
        the tissue makes a statement, made in writing and signed by the 
        woman, declaring that--
                    ``(A) the woman donates the fetal tissue for use in 
                research described in subsection (a);
                    ``(B) the donation is made without any restriction 
                regarding the identity of individuals who may be the 
                recipients of transplantations of the tissue; and
                    ``(C) the woman has not been informed of the 
                identity of any such individuals.
            ``(2) Additional statement.--In research carried out under 
        subsection (a), human fetal tissue may be used only if the 
        attending physician with respect to obtaining the tissue from 
        the woman involved makes a statement, made in writing and 
        signed by the physician, declaring that--
                    ``(A) in the case of tissue obtained pursuant to an 
                induced abortion--
                            ``(i) the consent of the woman for the 
                        abortion was obtained prior to requesting or 
                        obtaining consent for the tissue to be used in 
                        such research; and
                            ``(ii) no alteration of the timing, method, 
                        or procedures used to terminate the pregnancy 
                        was made solely for the purposes of obtaining 
                        the tissue;
                    ``(B) the tissue has been donated by the woman in 
                accordance with paragraph (1); and
                    ``(C) full disclosure has been provided to the 
                woman with regard to--
                            ``(i) such physician's interest, if any, in 
                        the research to be conducted with the tissue; 
                        and
                            ``(ii) any known medical risks to the woman 
                        or risks to her privacy that might be 
                        associated with the donation of the tissue and 
                        that are in addition to risks of such type that 
                        are associated with the woman's medical care.
    ``(c) Informed Consent of Researcher and Donee.--In research 
carried out under subsection (a), human fetal tissue may be used only 
if the individual with the principal responsibility for conducting the 
research involved makes a statement, made in writing and signed by the 
individual, declaring that the individual--
            ``(1) is aware that--
                    ``(A) the tissue is human fetal tissue;
                    ``(B) the tissue may have been obtained pursuant to 
                a spontaneous or induced abortion or subsequent to a 
                stillbirth; and
                    ``(C) the tissue was donated for research purposes;
            ``(2) has provided such information to other individuals 
        with responsibilities regarding the research;
            ``(3) will require, prior to obtaining the consent of an 
        individual to be a recipient of a transplantation of the 
        tissue, written acknowledgment of receipt of such information 
        by such recipient; and
            ``(4) has had no part in any decisions as to the timing, 
        method, or procedures used to terminate the pregnancy made 
        solely for the purposes of the research.
    ``(d) Availability of Statements for Audit.--
            ``(1) In general.--In research carried out under subsection 
        (a), human fetal tissue may be used only if the head of the 
        agency or other entity conducting the research involved 
        certifies to the Secretary that the statements required under 
        subsections (b)(2) and (c) will be available for audit by the 
        Secretary.
            ``(2) Confidentiality of audit.--Any audit conducted by the 
        Secretary pursuant to paragraph (1) shall be conducted in a 
        confidential manner to protect the privacy rights of the 
        individuals and entities involved in such research, including 
        such individuals and entities involved in the donation, 
        transfer, receipt, or transplantation of human fetal tissue. 
        With respect to any material or information obtained pursuant 
        to such audit, the Secretary shall--
                    ``(A) use such material or information only for the 
                purposes of verifying compliance with the requirements 
                of this section;
                    ``(B) not disclose or publish such material or 
                information, except where required by Federal law, in 
                which case such material or information shall be coded 
                in a manner such that the identities of such 
                individuals and entities are protected; and
                    ``(C) not maintain such material or information 
                after completion of such audit, except where necessary 
                for the purposes of such audit.
    ``(e) Applicability of State and Local Law.--
            ``(1) Research conducted by recipients of assistance.--The 
        Secretary may not provide support for research under subsection 
        (a) unless the applicant for the financial assistance involved 
        agrees to conduct the research in accordance with applicable 
        State and local law.
            ``(2) Research conducted by secretary.--The Secretary may 
        conduct research under subsection (a) only in accordance with 
        applicable State and local law.
    ``(f) Definition.--For purposes of this section, the term `human 
fetal tissue' means tissue or cells obtained from a dead human embryo 
or fetus after a spontaneous or induced abortion, or after a 
stillbirth.''.

SEC. 3. PURCHASE OF HUMAN FETAL TISSUE; SOLICITATION OR ACCEPTANCE OF 
              TISSUE AS DIRECTED DONATION FOR USE IN TRANSPLANTATION.

    Part G of title IV of the Public Health Service Act, as amended by 
section 2 of this Act, is amended by inserting after section 498A the 
following new section:

              ``prohibitions regarding human fetal tissue

    ``Sec. 498B. (a) Purchase of Tissue.--It shall be unlawful for any 
person to knowingly acquire, receive, or otherwise transfer any human 
fetal tissue for valuable consideration if the transfer affects 
interstate commerce.
    ``(b) Solicitation or Acceptance of Tissue as Directed Donation for 
Use in Transplantation.--It shall be unlawful for any person to solicit 
or knowingly acquire, receive, or accept a donation of human fetal 
tissue for the purpose of transplantation of such tissue into another 
person if the donation affects interstate commerce, the tissue will be 
or is obtained pursuant to an induced abortion, and--
            ``(1) the donation will be or is made pursuant to a promise 
        to the donating individual that the donated tissue will be 
        transplanted into a recipient specified by such individual;
            ``(2) the donated tissue will be transplanted into a 
        relative of the donating individual; or
            ``(3) the person who solicits or knowingly acquires, 
        receives, or accepts the donation has provided valuable 
        consideration for the costs associated with such abortion.
    ``(c) Criminal Penalties for Violations.--
            ``(1) In general.--Any person who violates subsection (a) 
        or (b) shall be fined in accordance with title 18, United 
        States Code, subject to paragraph (2), or imprisoned for not 
        more than 10 years, or both.
            ``(2) Penalties applicable to persons receiving 
        consideration.--With respect to the imposition of a fine under 
        paragraph (1), if the person involved violates subsection (a) 
        or (b)(3), a fine shall be imposed in an amount not less than 
        twice the amount of the valuable consideration received.
    ``(d) Definitions.--For purposes of this section:
            ``(1) The term `human fetal tissue' has the meaning given 
        such term in section 498A(f).
            ``(2) The term `interstate commerce' has the meaning given 
        such term in section 201(b) of the Federal Food, Drug, and 
        Cosmetic Act.
            ``(3) The term `valuable consideration' does not include 
        reasonable payments associated with the transportation, 
        implantation, processing, preservation, quality control, or 
        storage of human fetal tissue.''.

SEC. 4. REPORT BY GENERAL ACCOUNTING OFFICE ON ADEQUACY OF PROTECTIONS.

    (a) In General.--With respect to research on the transplantation of 
human fetal tissue for therapeutic purposes, the Comptroller General of 
the United States shall conduct an audit for the purpose of 
determining--
            (1) whether and to what extent such research conducted or 
        supported by the Secretary of Health and Human Services has 
        been conducted in accordance with section 498A of the Public 
        Health Service Act (as added by section 2 of this Act); and
            (2) whether and to what extent there have been violations 
        of section 498B of such Act (as added by section 3 of this 
        Act).
    (b) Report.--Not later than May 19, 1995, the Comptroller General 
of the United States shall complete the audit required in subsection 
(a) and submit to the Congress a report describing the findings made 
pursuant to the audit.

SOLUTION: Research on Human Fetal Tissue Amendments of 1993 - Amends the Public Health Service Act to authorize and regulate research on human fetal tissue transplantation without regard to whether the tissue is obtained after a spontaneous or induced abortion or a stillbirth in accordance with State law. 
Imposes criminal penalties for:  (1) transferring such tissue for valuable consideration affecting interstate commerce; or (2) soliciting or receiving a directed donation.

PROBLEM: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Access to Frontline Health Care Act 
of 2011''.

SEC. 2. FRONTLINE PROVIDERS LOAN REPAYMENT PROGRAM.

    Part D of title III of the Public Health Service Act (42 U.S.C. 
254b et seq.) is amended--
            (1) by redesignating the second subpart XI (as added by 
        section 10333 of Public Law 111-148) as subpart XII;
            (2) by redesignating the second section 340H (as added by 
        such section 10333) as section 340I; and
            (3) by adding at the end the following:

             ``Subpart XIII--Frontline Health Care Services

``SEC. 340J. FRONTLINE PROVIDERS LOAN REPAYMENT PROGRAM.

    ``(a) In General.--The Secretary shall establish and carry out a 
Frontline Providers Loan Repayment Program (in this section referred to 
as the `Loan Repayment Program') under which, pursuant to contracts in 
accordance with this section--
            ``(1) the Secretary agrees to make student loan repayments; 
        and
            ``(2) the individual agrees to serve as a health 
        professional for a period of full-time service of not less than 
        2 years at a health care facility serving a frontline care 
        scarcity area.
    ``(b) Eligibility.--To be eligible to participate in the Loan 
Repayment Program, an individual must--
            ``(1) submit an application to participate in the Loan 
        Repayment Program in such form and manner and at such time as 
        specified by the Secretary; and
            ``(2) sign and submit to the Secretary, at the time of 
        submittal of such application, a written contract (described in 
        subsection (d)).
    ``(c) Participation in Program.--
            ``(1) In general.--An individual becomes a participant in 
        the Loan Repayment Program only upon the approval of the 
        Secretary of the individual's application submitted under 
        subsection (b)(1) and the Secretary's acceptance of the 
        contract submitted by the individual under subsection (b)(2).
            ``(2) Preference.--In awarding contracts under this 
        section, the Secretary shall give preference to applicants who 
        have undertaken training or coursework in interdisciplinary 
        studies.
            ``(3) Recruitment for interdisciplinary programs.--The 
        Secretary shall--
                    ``(A) determine the frontline care scarcity areas 
                in which to place contract recipients under this 
                section; and
                    ``(B) in making such determination, give preference 
                to areas with a demonstrated program of 
                interdisciplinary health care, or with demonstrated 
                plans to initiate interdisciplinary approaches to 
                community health care.
            ``(4) Notice.--The Secretary shall provide written notice 
        to an individual promptly upon the Secretary's approving, under 
        paragraph (1), of the individual's participation in the Loan 
        Repayment Program.
    ``(d) Contract.--The contract described in this subsection is a 
written contract between the Secretary and an individual that 
contains--
            ``(1) an agreement that--
                    ``(A) the Secretary agrees to provide the 
                individual with student loan repayment (described in 
                subsection (e)) for a period of time as determined by 
                the Secretary, to pay off debts incurred during the 
                course of the study or program described in subsection 
                (g)(2)(B); and
                    ``(B) the individual agrees--
                            ``(i) to accept provision of such a student 
                        loan repayment to the individual; and
                            ``(ii) to provide frontline care services 
                        for a period of full-time service of not less 
                        than 2 years at a health care facility serving 
                        a frontline care scarcity area;
            ``(2) a provision that any financial obligation of the 
        United States arising out of a contract entered into under this 
        section and any obligation of the individual which is 
        conditioned thereon, is contingent upon funds being 
        appropriated for student loan repayment under this section;
            ``(3) a statement of the damages to which the United States 
        is entitled, under subsection (f), for the individual's breach 
        of the contract; and
            ``(4) such other statements as the Secretary deems 
        appropriate of the rights and liabilities of the Secretary and 
        of the individual, not inconsistent with the provisions of this 
        section.
    ``(e) Student Loan Repayment.--
            ``(1) Amount.--The amount of an annual student loan 
        repayment under this section on behalf of an individual shall 
        be determined by the Secretary, and shall take into 
        consideration the need to pay a sufficient amount to enable 
        recruiting of health care providers into the loan repayment 
        program under this section.
            ``(2) Payments directly to loan provider.--The Secretary 
        may contract with an individual's loan provider, for the 
        payment to the loan provider, on behalf of the individual, of 
        the amounts of a student loan repayment described in paragraph 
        (1).
    ``(f) Breach of Contract.--If an individual breaches a written 
contract under this section by failing to begin such individual's 
service obligation, or to complete such service obligation, the United 
States shall be entitled to recover from the individual an amount that 
is equal to the sum of--
            ``(1) the total amount which has been paid to the 
        individual, or on behalf of the individual, under the contract; 
        and
            ``(2) any amount of interest, as determined by the 
        Secretary.
    ``(g) Definitions.--In this section:
            ``(1) The term `frontline care scarcity area' means an 
        area, population group, or facility that--
                    ``(A) is designated as a health professional 
                shortage area under section 332; or
                    ``(B) is designated by the State in which the area 
                is located as having a shortage of frontline care 
                services.
            ``(2) The term `frontline care services' means health care 
        services--
                    ``(A) in the field of general surgery, optometry, 
                ophthalmology, chiropractic, physical therapy, 
                audiology, speech language pathology, pharmacies, 
                public health, podiatric medicine, dietetics, 
                occupational therapy, general pediatrics, respiratory 
                therapy, medical technology, otolaryngology, or 
                radiologic technology; and
                    ``(B) provided by a general surgeon, optometrist, 
                ophthalmologist, chiropractor, physical therapist, 
                audiologist, speech language pathologist, pharmacist, 
                public health professional, podiatric physician, 
                registered dietician, occupational therapist, 
                pediatrician, respiratory therapist, medical 
                technologist, otolaryngologist, or radiologic 
                technologist who has completed an appropriate course of 
                study or program, offered by an accredited institution 
                of higher education in the United States.
    ``(h) Implementation.--The Secretary shall begin implementation of 
the loan repayment program under this section within 180 days of the 
date of the enactment of this section.''.

SOLUTION: Access to Frontline Health Care Act of 2011 - Amends the Public Health Service Act to direct the Secretary of Health and Human Services (HHS) to establish and carry out a Frontline Providers Loan Repayment Program under which the Secretary agrees to make student loan repayments in exchange for a health professional providing frontline care services for two years in a frontline care scarcity area. Defines "frontline care services" as health care services in the fields of general surgery, optometry, ophthalmology, chiropractic, physical therapy, audiology, speech language pathology, pharmacies, public health, podiatric medicine, dietetics, occupational therapy, general pediatrics, respiratory therapy, medical technology, otolaryngology, or radiologic technology.

PROBLEM: SECTION 1. SHORT TITLE.

    This Act may be cited as ``Lali's Law''.

SEC. 2. OPIOID OVERDOSE REVERSAL MEDICATION ACCESS AND EDUCATION GRANT 
              PROGRAMS.

    (a) Technical Clarification.--Effective as if included in the 
enactment of the Children's Health Act of 2000 (Public Law 106-310), 
section 3405(a) of such Act (114 Stat. 1221) is amended by striking 
``Part E of title III'' and inserting ``Part E of title III of the 
Public Health Service Act''.
    (b) Amendment.--Title III of the Public Health Service Act is 
amended by inserting after part D of such title (42 U.S.C. 254b et 
seq.) the following new part E:

                     ``PART E--OPIOID USE DISORDER

``SEC. 341. OPIOID OVERDOSE REVERSAL MEDICATION ACCESS AND EDUCATION 
              GRANT PROGRAMS.

    ``(a) Grants to States.--The Secretary may make grants to States 
for--
            ``(1) developing standing orders for pharmacies regarding 
        opioid overdose reversal medication;
            ``(2) encouraging pharmacies to dispense opioid overdose 
        reversal medication pursuant to a standing order;
            ``(3) implementing best practices for persons authorized to 
        prescribe medication regarding--
                    ``(A) prescribing opioids for the treatment of 
                chronic pain;
                    ``(B) co-prescribing opioid overdose reversal 
                medication with opioids; and
                    ``(C) discussing the purpose and administration of 
                opioid overdose reversal medication with patients;
            ``(4) developing or adapting training materials and methods 
        for persons authorized to prescribe or dispense medication to 
        use in educating the public regarding--
                    ``(A) when and how to administer opioid overdose 
                reversal medication; and
                    ``(B) steps to be taken after administering opioid 
                overdose reversal medication; and
            ``(5) educating the public regarding--
                    ``(A) the public health benefits of opioid overdose 
                reversal medication; and
                    ``(B) the availability of opioid overdose reversal 
                medication without a person-specific prescription.
    ``(b) Certain Requirement.--A grant may be made under this section 
only if the State involved has authorized standing orders regarding 
opioid overdose reversal medication.
    ``(c) Preference in Making Grants.--In making grants under this 
section, the Secretary shall give preference to States that--
            ``(1) have not issued standing orders regarding opioid 
        overdose reversal medication;
            ``(2) authorize standing orders that permit community-based 
        organizations, substance abuse programs, or other nonprofit 
        entities to acquire, dispense, or administer opioid overdose 
        reversal medication;
            ``(3) authorize standing orders that permit police, fire, 
        or emergency medical services agencies to acquire and 
        administer opioid overdose reversal medication;
            ``(4) have a higher per capita rate of opioid overdoses 
        than other applicant States; or
            ``(5) meet any other criteria deemed appropriate by the 
        Secretary.
    ``(d) Grant Terms.--
            ``(1) Number.--A State may not receive more than one grant 
        under this section.
            ``(2) Period.--A grant under this section shall be for a 
        period of 3 years.
            ``(3) Amount.--A grant under this section may not exceed 
        $500,000.
            ``(4) Limitation.--A State may use not more than 20 percent 
        of a grant under this section for educating the public pursuant 
        to subsection (a)(5).
    ``(e) Applications.--To be eligible to receive a grant under this 
section, a State shall submit an application to the Secretary in such 
form and manner and containing such information as the Secretary may 
require, including detailed proposed expenditures of grant funds.
    ``(f) Reporting.--Not later than 3 months after the Secretary 
disburses the first grant payment to any State under this section and 
every 6 months thereafter for 3 years, such State shall submit a report 
to the Secretary that includes the following:
            ``(1) The name and ZIP Code of each pharmacy in the State 
        that dispenses opioid overdose reversal medication under a 
        standing order.
            ``(2) The total number of opioid overdose reversal 
        medication doses dispensed by each such pharmacy, specifying 
        how many were dispensed with or without a person-specific 
        prescription.
            ``(3) The number of pharmacists in the State who have 
        participated in training pursuant to subsection (a)(4).
    ``(g) Definitions.--In this section:
            ``(1) Opioid overdose reversal medication.--The term 
        `opioid overdose reversal medication' means any drug, including 
        naloxone, that--
                    ``(A) blocks opioids from attaching to, but does 
                not itself activate, opioid receptors; or
                    ``(B) inhibits the effects of opioids on opioid 
                receptors.
            ``(2) Standing order.--The term `standing order' means a 
        document prepared by a person authorized to prescribe 
        medication that permits another person to acquire, dispense, or 
        administer medication without a person-specific prescription.
    ``(h) Authorization of Appropriations.--
            ``(1) In general.--To carry out this section, there is 
        authorized to be appropriated $5,000,000 for the period of 
        fiscal years 2017 through 2019.
            ``(2) Administrative costs.--Not more than 3 percent of the 
        amounts made available to carry out this section may be used by 
        the Secretary for administrative expenses of carrying out this 
        section.''.

SEC. 3. CUT-GO COMPLIANCE.

    Subsection (f) of section 319D of the Public Health Service Act (42 
U.S.C. 247d-4) is amended by inserting before the period at the end the 
following: ``(except such dollar amount shall be reduced by $5,000,000 
for fiscal year 2017)''.

            Passed the House of Representatives May 12, 2016.

            Attest:

                                                 KAREN L. HAAS,

                                                                 Clerk.

SOLUTION:
(This measure has not been amended since it was reported to the House on May 10, 2016.  Lali's Law (Sec. 2) This bill amends the Public Health Service Act to permit the Department of Health and Human Services to make grants to states that allow standing orders (documents that allow a person to acquire, dispense, or administer a prescription medication without a person-specific prescription) for opioid overdose reversal medication (e.g., naloxone). (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.) Grants may be used for:   developing standing orders for opioid overdose reversal medication for pharmacies; encouraging pharmacies to dispense medication pursuant to such a standing order; implementing best practices for prescribing opioids, prescribing opioid overdose reversal medication with opioids, and discussing opioid overdose reversal medication with patients; developing training for prescribers to use in educating the public on administration of opioid overdose reversal medication; and educating the public on the availability and public health benefits of opioid overdose reversal medication.  States must report on pharmacies that dispense opioid overdose reversal medication under a standing order and the number of pharmacists trained in educating the public on administration of opioid overdose reversal medication.  (Sec. 3) As an offset, this bill reduces the authorization of appropriations for Centers for Disease Control and Prevention facilities.